Myristoyl Tetrapeptide-12
| 제품명 | Myristoyl Tetrapeptide-12 |
|---|---|
| CAS 번호 | 959610-54-9 |
| 외관 | 흰색에서 미색의 분말 |
| 사양 | ≥98% (HPLC) |
| 분자식 | C35H63N7O7 |
| 분자량 | 693.9 g/mol |
| 용해도 | Soluble in water, ethanol, and propylene glycol |
| 패키지 | 1 kg, 5 kg, 10 kg (net weight in aluminum foil bags or fiber drums) |
도움이 필요하신가요? 저희 팀에 문의해 주세요

Synonyms: Myristoyl Tetrapeptide-12, N-Myristoyl Tetrapeptide-12, Myristoyl Tetrapeptide-12 (INCI), CAS 959610-54-9
Myristoyl Tetrapeptide-12 is a synthetic lipopeptide consisting of a tetrapeptide backbone acylated with myristic acid at the N-terminus. The sequence—typically comprising glycine, histidine, and lysine residues—is designed to mimic the active site of human parathyroid hormone-related protein (PTHrP), a natural regulator of melanogenesis. This modification enhances lipophilicity and skin penetration, making it a valuable active in cosmetic formulations aimed at pigmentation control.
Since its introduction, Myristoyl Tetrapeptide-12 has gained attention as a non-hydroquinone alternative for hyperpigmentation. It operates by interfering with tyrosinase activity and melanocyte-stimulating hormone (MSH) signaling, thereby reducing melanin synthesis. Unlike conventional whitening agents, it does not cause cytotoxicity to melanocytes, offering a gentler approach to skin lightening.
The peptide is produced via solid-phase peptide synthesis, followed by myristoylation and high-performance liquid chromatography (HPLC) purification. It is supplied as a white to off-white powder, standardized to ≥98% purity, and is compatible with a wide range of cosmetic delivery systems, including emulsions, serums, and gels.
| 매개변수 | 사양 |
|---|---|
| 분석법 (HPLC) | ≥98.0% |
| 식별 | Conforms to structure |
| 외관 | 흰색에서 미색의 분말 |
| 건조 손실 | ≤5.0% |
| 소각 잔류물 | ≤1.0% |
| 중금속 | ≤10 ppm |
| Microbial Limits | Total aerobic count ≤1000 CFU/g; Yeast & Mold ≤100 CFU/g; E. coli absent |